T. Rowe Price Associates »

Enliven Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $298k 12k 25.59
2024-06-30 $262k 11k 23.38